BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  TherapeuticsMD Announces Full Year 2025 Financial Results

  March 31, 2026

   · 

  4 min read
• Press Releases

  PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data

  March 31, 2026

   · 

  8 min read
• Press Releases

  Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

  March 31, 2026

   · 

  19 min read
• Press Releases

  DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights

  March 31, 2026

   · 

  13 min read
• Press Releases

  Cancer Vaccine Coalition Commits $1 Million to Try to Stop Breast Cancer Recurrence Before It Starts

  March 31, 2026

   · 

  3 min read
• Press Releases

  Alvotech Publishes 2025 Annual Report

  March 31, 2026

   · 

  1 min read
• Press Releases

  Alvotech files Annual Report with the SEC

  March 31, 2026

   · 

  1 min read
• Press Releases

  Lipella Pharmaceuticals Inc. Files Voluntary Petitions for Relief Under Chapter 11

  March 31, 2026

   · 

  1 min read
• Press Releases

  Innovent’s Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema

  March 31, 2026

   · 

  10 min read
• Press Releases

  Emmaus Life Sciences Reports Annual Financial Results

  March 31, 2026

   · 

  7 min read